Press release
Lung Cancer Surgery Market Gains Momentum with Advances in Preoperative Imaging & AI-Guided Surgical Planning | Ethicon US LLC, Intutive Surgical Inc, Olympus Corporation, Accuray Inc
"The Lung Cancer Surgery Market is estimated to reach at a high CAGR during the forecast period (2024-2031)«One_Liner»" As per DataM intelligence research reportMarket growth opportunities(2025-2031):
The global lung cancer surgery market is expanding steadily, propelled by rising lung cancer cases and early detection that increase surgical volumes. Minimally invasive approaches such as VATS and robotic-assisted thoracic surgery are gaining prominence, reducing recovery time and enhancing precision. Technological innovation in surgical instruments, imaging, navigation, and modular operating suites accelerates adoption in diverse settings. Growth is supported by increasing outpatient and ambulatory surgical centers enabled by less-invasive workflows. Asia-Pacific represents a high-growth region complementing steady innovation in North America and Europe.
Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/lung-cancer-surgery-market?sp
Lung cancer surgery Market: Recent Industry Developments
✅ In May 2025, Intuitive Surgical launched the da Vinci 5 System globally, including availability in top thoracic centers in the U.S., Japan, and Europe. Designed for lung resections and segmentectomies, it features enhanced tactile feedback, AI-guided imaging, and improved console ergonomics.
✅ In April 2025, Medtronic unveiled its HugoTM Robotic-Assisted Surgery (RAS) system at key teaching hospitals in Asia, enabling lung cancer surgeries with greater precision and smaller incisions. Early studies show faster recovery times and reduced complications in lobectomies.
✅ In March 2025, Johnson & Johnson's Ethicon division introduced the ECHELONTM 3000 Powered Stapler, optimized for thoracic surgeries including lobectomy and wedge resections. It features adaptive firing technology and enhanced articulation for complex lung procedures.
✅ In February 2025, Broncus Medical received FDA 510(k) clearance for its LungPoint® Navigation System, which supports preoperative planning and precise localization of small pulmonary nodules during video-assisted thoracoscopic surgery (VATS).
✅ In January 2025, Siemens Healthineers introduced AI-powered CT navigation software tailored for lung cancer surgery, enabling surgeons to simulate tumor removal and assess margin status pre-surgery. It is now being piloted in major U.S. cancer centers.
Lung cancer surgery Market: Drivers
A growing lung cancer incidence and screening uptake are key demand forces. Precision surgery enabled by robotics, AI-assisted planning, and endoscopic devices enhances procedural effectiveness and surgeon confidence. Advancements in ergonomic and disposable surgical instrument designs address infection control and streamline workflows. Favorable reimbursement policies in mature markets and expansion of ambulatory surgical centers further boost surgical volumes. Hybrid OR setups combining imaging and surgical tools support tumor localization and real-time guidance
Strategic Players Driving the Lung cancer surgery Market Forward:
Ethicon US LLC, Intutive Surgical Inc, Olympus Corporation, Accuray Inc, AngioDynamics Inc, Teleflex Inc., Shanghai Ezisurg Medical (PRC), SShanghai Bojin Medical Instrument Co., Ltd., (PRC), Taizhou Rich Medical Products Co. (PRC), Ltd., Zhejiang Honsun Medical Technology Co., Ltd. (PRC) among others
Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/lung-cancer-surgery-market?sp
Segment Covered in the Lung cancer surgery Market:
➥By Surgical Devices: Surgical Instruments, Hand Instruments, Monitoring and Visualizing Systems
➥By Surgical Procedures: Thoracotomy, Lobectomy, Sleeve Resection, Segmentectomy, Pneumonectomy, Minimally Invasive Surgeries
➥By End User: Hospitals, Clinics, Ambulatory Surgical Centers
Regional Analysis for Lung cancer surgery Market:
North America leads the market with advanced infrastructure, high adoption of robotic and minimally invasive techniques, and strong early-stage diagnosis systems via screening programs. Europe follows with integrated healthcare systems and growing minimally invasive procedures. Asia Pacific is the fastest-growing market; rising cancer burden, expanding hospital capacity, and greater access to surgical technologies fuel rapid uptake in countries such as China, India, and Japan
Why Purchase the Report for Lung cancer surgery Market?:
➠ Technology & Innovation: Tracks clinical trials and upcoming pharmaceutical advancements to stay ahead in product development.
➠ Market Positioning & Competitive Strategy: Analyzes product performance, market share, and competitor tactics for strategic decision-making.
➠ Real-World Evidence & Physician Insights: Incorporates patient data and physician behavior to align products with actual healthcare needs.
➠ Pricing & Market Access: Reviews reimbursement trends and access models to optimize product pricing and launch strategies.
➠ Regulatory & Industry Shifts: Covers policy changes, health system dynamics, and technology trends impacting market opportunities.
➠ Regional Growth & Expansion: Identifies high-growth markets and investment opportunities for geographic expansion.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=lung-cancer-surgery-market?sp
Conclusion:
As lung cancer surgery shifts toward minimally invasive, data-driven procedures, demand for advanced instrumentation, imaging systems, and robotics will continue to rise. Hospitals remain the dominant end-user segment, though ambulatory surgical centers are gaining share thanks to shorter stays and outpatient capabilities. Surgical devices-particularly monitoring/visualization tools and instruments-form the core enabling technologies. Stakeholders focusing on precision, interoperability, and regional expansion will be well-positioned to capitalize on the evolving market
Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lung Cancer Surgery Market Gains Momentum with Advances in Preoperative Imaging & AI-Guided Surgical Planning | Ethicon US LLC, Intutive Surgical Inc, Olympus Corporation, Accuray Inc here
News-ID: 4131496 • Views: …
More Releases from DataM intelligence 4 Market Research LLP

United States Biologics Contract Manufacturing Market Accelerates with Growing B …
Outsourced biologics manufacturing including monoclonal antibodies (mAbs), vaccines, and advanced therapies such as cell and gene treatments has become essential to driving biopharma innovation. According to DataM Intelligence, the global biologics contract manufacturing market was valued at USD 26.03 billion in 2024 and is projected to reach USD 83.47 billion by 2033, expanding at a CAGR of 14.0% between 2025 and 2033.
Download exclusive insights with our detailed sample report (Corporate…

United States Healthcare Data Monetization Market Fueled by Growing Demand for R …
Healthcare data monetization involves transforming patient, claims, EHR, genomic and device-generated information into actionable insights and services. Based on DataM Intelligence analysis, the market was valued at approximately USD 0.6 billion in 2024 and is projected to reach USD 1.35 billion by 2031, reflecting a compound annual growth rate (CAGR) of 19.2%.
The accelerating adoption of artificial intelligence, real-world evidence generation, and cloud analytics platforms are key drivers behind this rapid…

Plant-Based Meat Market 2025 | Growth Drivers, Key Players & Investment Opportun …
Market Size and Growth
Global Plant-based Meat Market reached USD 5.6 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 21.7 billion by 2031. The market is expected to exhibit a CAGR of 20.2% during the forecast period (2024-2031).
Key Development:
United States: Recent Industry Developments
✅ In July 2025, Impossible Foods launched grilled plant-based chicken strips nationwide, expanding its product line to cater to the growing demand…

United States Detox Drinks Market Outlook | Market Drivers, Innovation & Investo …
Market Size and Growth
Global Detox Drinks Market is expected to exhibit a CAGR of 6.52% during the forecast period (2024-2031).
Key Development:
United States:
✅ In August 2025, PepsiCo launched its Prebiotic Cola, a soda with 30 calories, no artificial sweeteners, and three grams of prebiotic fiber. This move reflects the company's response to the growing demand for functional beverages.
✅ In May 2025, PepsiCo acquired prebiotic soda company Poppi for $1.95 billion,…
More Releases for Lung
Lung Cancer Prevalence Driving The Lung Cancer Drugs Market: Core Growth Enabler …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Lung Cancer Drugs Industry Market Size Be by 2025?
The market for lung cancer medications has seen a swift expansion in previous years. The market size is projected to escalate from $47.94 billion in 2024 to $54.13 billion in 2025, with a compound annual growth rate…
Lung Cancer Prevalence Driving The Lung Cancer Drugs Market: An Emerging Driver …
The Lending And Payments Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Lending And Payments Market?
The lending and payments market has experienced strong growth in recent years. It is set to rise from $12,326.44 billion in 2024 to…
Transforming the Lung Cancer Drugs Market in 2025: Lung Cancer Prevalence Drivin …
What Is the Expected Size and Growth Rate of the Lung Cancer Drugs Market?
The market size for lung cancer medications has seen swift expansion in the recent past. Its growth is projected to surge from $47.94 billion in 2024 to $54.13 billion in 2025, marking a compound annual growth rate (CAGR) of 12.9%. Factors contributing to the historical period's growth include epidemiology and demographics, regulatory authorizations, healthcare system infrastructure, and…
Transforming the Lung Cancer Drugs Market in 2025: Lung Cancer Prevalence Drivin …
What Is the Expected Size and Growth Rate of the Lung Cancer Drugs Market?
The market size for lung cancer medications has seen swift expansion in the recent past. Its growth is projected to surge from $47.94 billion in 2024 to $54.13 billion in 2025, marking a compound annual growth rate (CAGR) of 12.9%. Factors contributing to the historical period's growth include epidemiology and demographics, regulatory authorizations, healthcare system infrastructure, and…
Lung Cancer Screening Market - Empowering Proactive Lung Health: The Future of C …
Newark, New Castle, USA: The "Lung Cancer Screening Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Lung Cancer Screening Market: https://www.growthplusreports.com/report/lung-cancer-screening-market/7787
This latest report researches the industry structure,…
Artificial Lung Market May Set New Growth Story | Breethe, Lung Biotechnology, M …
A new research document is added in HTF MI database of 37 pages, titled as 'Artificial Lung - Medical Devices Pipeline Assessment, 2020' with detailed analysis, Competitive landscape, forecast and strategies. The study covers important players/vendors such as ALung Technologies Inc, Breethe, Inc., Case Western Reserve University, Lung Biotechnology PBC, MC3 Inc, McGowan Institute for Regenerative , Medicine, Miromatrix Medical Inc, The Charles Stark Draper Laboratory Inc, U.S. Ann Arbor…